← Back to BCAB

BioAtla, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 15/05/2026Sep 2025Filed 13/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 15/05/2026Sep 2024Filed 13/11/2025Jun 2024Filed 07/08/2025Mar 2024Filed 06/05/2025
$0.5−$6.3−$16−$19−$15−$11−$21−$23
$0.27−$4.22−$0.27−$15.99−$13.16−$0.22−$0.44−$0.48
1.71.5591.21.2484848

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.